Old Diabetes Drug Is New Cancer Treatment

Old Diabetes Drug is a New Cancer Treatment

A diabetes drug permitted in 1958 could be the newest cancer treatment. At an amazingly low price, it potentially  offers protection against at least six common sorts of cancer.

It is called Meformin (Glucophage), an old drug, commonly used to lower the blood sugar in type 2 diabetics, but can as well be the next new cure for breast cancer, colon cancer, and prostate cancer — it can also give you an idea about a promise for fighting oral cancer, pancreatic cancer and liver cancer.

As to Bloomberg News, Melformin, which only cost 47 cents per pill, is being studied as a potential treatment in approximately 50 cancer studies around the world. Interest piqued when the statement got out that the medicine could not only lower blood sugar in people, but it can also prevent cancer in animal studies. What’s more is that the drug appears to be related with lower rates of cancer in diabetes patients.

According to an analysis of seven studies together with more than 30,000 patients, Melformin reduced on the whole cancer risk by 38 percent in people with type 2 diabetes as well.

In a 2009 study carried out by the M.D. Anderson Center published in Gastroenterology also found a significant decrease in risk of pancreatic cancer for diabetes patients.

Moreover, a research published in PLos One shows that Melformin lessen the risk of breast cancer by putting a stop to chemicals from stimulating the growth of cancer cells.

In addition to reducing the risk of cancer, Melformin can also slow the increase of cancer cells in diabetic men with prostate cancer.

Posted by George Daniels on Wednesday October 10 2012, 2:18 AM EST. Ref: Google. All trademarks acknowledged. Filed under Featured News, Health. Comments and Trackbacks closed. Follow responses: RSS 2.0